These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 2156105)

  • 1. [Serum level of digoxin-like immunoreactive substances in newborn infants in the first two weeks of life, in umbilical cord blood and in pregnant patients at the time of labor].
    Gawaz MP; Schreiber R; Vogt W; Genz T; Kellner M
    Klin Padiatr; 1990; 202(1):31-6. PubMed ID: 2156105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Digoxin-like immunoreactivity in newborn infants--a pitfall of digoxin therapy?].
    Heise HR; Vorwerk P; Fritsche K; Richter R
    Kinderarztl Prax; 1993 May; 61(3):108-11. PubMed ID: 8326698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal changes in a digoxin-like immunoreactive substance.
    Seccombe DW; Pudek MR; Whitfield MF; Jacobson BE; Wittmann BK; King JF
    Pediatr Res; 1984 Nov; 18(11):1097-9. PubMed ID: 6514436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the presence of digoxin-like immunoreactive substance (DLIS) in the serum and urine in children with nephrotic syndrome.
    Shimabukuro N; Ebara H; Maruyama K; Tomizawa S; Kuroume T
    Clin Nephrol; 1988 May; 29(5):244-7. PubMed ID: 2840225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous digoxin-like immunoreactivity during pregnancy and at birth.
    Lupoglazoff JM; Jacqz-Aigrain E; Guyot B; Chappey O; Blot P
    Br J Clin Pharmacol; 1993 Mar; 35(3):251-4. PubMed ID: 8471401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin-like immunoreactive substance in serum of preterm and full-term neonates.
    Bertrand JM; Langhendries JP; Gras A; Battisti O
    Eur J Pediatr; 1987 Mar; 146(2):145-6. PubMed ID: 3032639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endogenous digoxin-like substance (nonspecific interference or a new hormone?)].
    Kovács L; Lichardus B; Bircák J; Benetínová J; Ponecová M; Masurová A; Stefaníková J
    Cesk Pediatr; 1989 Feb; 44(2):73-5. PubMed ID: 2720827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous cardiac glycoside-like substances in newborns, adults, pregnant women and patients with hypertension or renal insufficiency.
    Clerico A; Balzan S; Del Chicca MG; Paci A; Cocci F; Bertelli A
    Drugs Exp Clin Res; 1988; 14(9):603-7. PubMed ID: 3229323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous digoxin-like immunoreactivity in elderly patients with normal serum creatinine concentrations.
    Lackner TE; Lau BW; Parvin C; Valdes R
    Clin Pharm; 1988 Jun; 7(6):449-53. PubMed ID: 3402180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Observations on serum digoxin-like immunoreactive substances in patients with cor-pulmonale].
    Shi YS; Liu JH; Yu XZ
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(4):229-31. PubMed ID: 8156846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal endoxins and complications of pregnancy.
    Goodlin RC; Makowski EL
    West J Med; 1988 May; 148(5):590-2. PubMed ID: 2845675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between digoxin-like immunoreactivity and electrolyte values in urinary samples of newborns.
    Clerico A; Boldrini A; Del Chicca MG; Biver P; Fantoni M; Mezzasalma L; Fassorra C; Cipolloni C
    Biol Neonate; 1986; 50(1):27-35. PubMed ID: 3755623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin-like immunoreactive substance in postmortem blood of infants and children.
    Spiehler VR; Fischer WR; Richards RG
    J Forensic Sci; 1985 Jan; 30(1):86-91. PubMed ID: 3981124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship among intrauterine growth, insulinlike growth factor I (IGF-I), IGF-binding protein-3, and bone mineral status in newborn infants.
    Akcakus M; Koklu E; Kurtoglu S; Kula M; Koklu SS
    Am J Perinatol; 2006 Nov; 23(8):473-80. PubMed ID: 17094045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of atrial natriuretic peptide and digoxin-like immunoreactive substance during pregnancy.
    Shrivastav P; Gill DS; D'Souza V; O'Brien PM; Dandona P
    Clin Chem; 1988 May; 34(5):977-80. PubMed ID: 2967132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous digitalis-like factors.
    Graves SW
    Crit Rev Clin Lab Sci; 1986; 23(3):177-200. PubMed ID: 3015491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic activity of digoxin-like immunoreactive substance extracted from cord blood.
    Ebara H; Suzuki S; Nagashima K; Kuroume T
    Life Sci; 1988; 42(3):303-9. PubMed ID: 2826960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin-like immunoreactive substance: monoclonal and polyclonal RIA and FPIA compared.
    Mojaverian P; Green PJ; Jhangiania RK; Chase GD
    J Pharm Biomed Anal; 1989; 7(5):585-92. PubMed ID: 2490762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Chinese medicine "kyushin" on serum digoxin concentration measurement in dogs.
    Lin CS; Lin MC; Chen KS; Liu CB
    Jpn Circ J; 1989 Feb; 53(2):108-12. PubMed ID: 2716172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.